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Introduction
The launch ofthe WHO Boneand Joint Decade(BJD)
2000-20lOis a culmination of the efforts put in by
numerous experts and visionaries to curb the growing
menace of the rheumatic and musculoskeletal diseases
(RMSD). These disorders, inclusive of the traumatic
aetiology, predominantlycontributeto the morbidityacross
the globe. in terms ofimpaired quality oflife (QOL).
After having effectively launched -several programs
to control Ilumerous commUI1 icable infectious diseases
with a fair measure ofsuccess over the decades, WHO
has now begun to increasingly focus on the non-
communicable diseases. Amongst the latter, the
cardiovascular disorders and cancers have preoccupied
the health planners for reasons obviously connected to
human longevity. But having realized that reduction in
mortality must be matched with improved QOL, WHO
has now launched one of its most ambitious programs,
the WHO-BJD 2000-2010.
Initiated by the medical faculty of the Swedish
University at Lund, the inaugural consensus meeting
was held in April 1998 to. setup an international
BJD International steering group. Further, a proposal
for a global collaboration by the latter was accepted
byWIIO.
SecretGlYGeneralKajiAnnan, on behalfofthe Uniled
Nations, has offiCiallywelcomedthe WHO-BJD initialive.
andhas appealedto the Worldcommunity in stating Ihat
'there areeffeclive ways topreventortreat thesedisabling
conditions. But we /Ilusl act on them (RMSD) nOly.
The BJD is actually an umbrella organization ofover
750 patient and professional organizations in the World
concerned with bone and joint disorders. It is endorsed
by the International League of Associations for
Rheumatology (ILAR) and its components in Asia-
Pacific (APLAR), and rest of the World. Numerous
national organizations, including the Indian Orthopedic
Association and the Indian Rheumatism Association,
have been listed amongst the organizations supporting
the BJ Dmovemen1. Over 17 Governments have endorsed
the WHO-BJD project. The Government of India has
yet to offer its official support.
The WHO proceeded to organize a scientific expe'1
group meeting in Geneva, Switzerland, in Jan. 2000 for
the official launch ofthe BJD. To begin with, this meeting
focussed on 5 major disorders amongst the. many that
constitute RMSD. These were rheumatoid arthritis (RA),
osteoarthritis (OA), osteoporosis, spinal disorders and
severe Iimb trauma.
Background Information & Inaugural Addresses
Althritisaccounts for over 50%ofall chronicconditions
in persons aged 60 years and above.ln over 25% of the
latter community, OA of the knees and spine, causes
dominant pain and disability. Back pain, one of the
commonest cause ofseeking medical consultation, is the
second leading cause of sick leave from work. About
10-20 % ofpopulation visit the doctorfor all kinds ofsoft
tissue rheumatism and trauma related MSD, and the lalter
are often related to occupational overuse andlor misuse.
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Dr Jie Chen, Director, Non-Communicable Diseases
Division, WHO, in her inaugural speech stated that
currently there are about 12 million cases ofrheumatic
heartdisease(RHD) reported alllltJallyall overthe World.
It must be added that RHD is caused by rheumatic fever
which if diagnosed early and treated appropriately is
curable. Rheumatic fever, a post bacterial disorder, is a
preventable and a major scourgeofyoung population in
the developing countries.
It is anticipated that based on current trends, road
traffic accidents (RTA), already in epidemic
proportions, would compete with cardiac and vascular
disordersand cancersto beamongst the3 leadingcauses
of human mortality and morbidity by 2020.Almost,
700,000 people are killed globally by RTA, which are
estimated to be the tenth leading cause ofdeath (World
Health Report, 1999). Twenty-five percentofthe health
expenditure in the developing countries is expected to
be spenton trauma related care by theyear20IO. Fragility
fractures, due to osteoporosis, have doubled in the last
decade, and it is estimated that over 40% ofall women
over the age of50 years (as women are more likely to
suffer ftom osteoporosis after menopause) will suffer
from an osteoporotic fracture. Prof. Lars Lidgren,
Chairman, BJD International SteeringCommittee, in his
inaugural addressstated that the numberofhip fractures
will further rise from 1.7 million in 1990 to 6.3 million
by 2050 unless aggressive preventive programs are
started.
In the inaugural address to the meet, Dr. Gro
Harlem Brundtland,DirectorGeneral,WHO,stated
that"theincreased life expectancy recorded in recent
decades, together with changes in life'style and diet,
have lead to a rise in non-communicable diseases
(NCD), also ill the developing countries.NCD now
cause nearly 40% of all deaths in the developing
cOllntries, where they affect younger people than in
industrialized countries." The latter underscores the
significanceoftheNCD, including WHO-BJD, allover
thf World.
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Scientific Meeting Program & Deliberations ,
Over 70 expert participants, belonging to different
fields (Rheumatology, orthopedics, epidemiology,
social sciences, statistics, economics, health planning.
etc), from all overthe world were invited. Prof. Anthony
Woolf, a rheumatologist from UK, was electedchairman
ofthe meeting.
Prof Shanmugasundaram, (Madras Orthopedic
Surgeon), Dr. Arvind Chopra (Pune, Rheumatologist),
Dr. A Miltal (Delhi, endocrinologist), andProf D. Mohan
(Delhi, Trauma Expert), were invitedfrom India.
The participants weredivided into 5 working groups,
one each for RA, OA, trauma, osteoporosis and spinal
disorders.
The 2 day program consisted of key lectures and
workshop-brain storming sessions to
(i) review the existing epidemiological data on
RMSD.
(ii) achieveconsensuson diseasedefinitions, staging
and natural history.
(iii) identify health and socioeconomic indicatorsof
RMSD.
(iv) identify gaps in the knowledge and
understanding ofRMSD.
(v) raise awareness ofthe BJD.
The currently available validated instruments to
measure health status,diseaseoutcomeand overall QOL
were discussed in detail for future adoption to measure
the burden ofdisease, with particularreferenceto socio-
economics. Thedisability adjusted life year methodology
(DALY), based on health and socia-economic indicators,
was presented by WHO experts with a view to measure
the RMSD burden quantitatively in a standardized
manner from all countries, irrespective of their
developmentstatus. Similarly, DALY could be calculated
for all other diseases, and then be used to allot health
expenditure priorities.
The WHO also presented the new classification
nomenclature of diseases, and their functioning and
disability. The well known WHO model paradigm of
impairment-disability-handicap to describe disease
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consequences will be replaced by the 'impairment-
activity-participation' model for better humane
connotations and acceptance.
The conclusions ofthe 5 working groups, one for each
of the major RMSD disorders described above, were
presented, discussed and a consensusofthe participants
obtained. Differences in opinions were recorded. A
research agenda was conceptualized.Items to be
contained in the future strategy ofBJD were discussed
with a viewto fill the 'gaps' identified during thi~meeting
through organized global effort, devise appropriate
interventions for reduction in the RMSD burden and
provide better health care and health.
The WHO will publish the proceedings of this
scientific meeting through a WHO Technical Report.
The Indian Participation & Data
The epidemiologicaldata on RMSDgeneratedbythe
WHO COPCORD (community orientedprogrammefor
control of rheumatic diseases) project in village
Bhigwan, District Pune, India was accepted and listed
in the BJD global data inventory.
The Bhigwan COPCORD, the firstofits kind in India,
and seventh in the World, was launched in 1996, under
the auspices ofthe WHO-ILAR-APLARCOPCORD by
Dr. Arvind Chopra, a consulting rheumatologist in Pune,
India. The Bhgiwan COPCORD 1996-2004 is the first
ongoing prospective study of its kind in the World, and
has provided prevalence and incidence figures ofvarious
types of RMSD from a 7000 rural population.
It was recognised during the WHO meeting under
reference that the Bhigwan COPCORD had amply
shown :-
(i) about 13-14 % ofpopulation reported RMSD
symptoms andreqUired medicalcare
(ii) besides the 5 major RMSD entities underfocus,
soft tissue rheumatism problems (STR) are
dominantly reportedbyalmost 55%ofthe RMSD
rural patients, a fact that was endorsed by the
partcipantsforevaluation on andinclusion in the
BJDagenda.. STRproblems, dominantly reported
by working female class, were largely due to
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occupationaloveruse, alsocalledrepetitivestress
syndr()me in this village. Psychofunctional
factors, especiallyanxiety, can also leadto aform
ofSTR, often calledjibromyalgia but the lalter
through searched in the village population was
much less. Overall, STRproblemsarepreventable
andamenable to treatmentlargely byappropriate
health education.
(iii) almost 10% of the RMSD patients had
inflammatory arthritis, andthat the prevalence
ofRA was almost 5.5-0.6% in the Bhigwan
population; the highest ever reported from a
rural studyofthis kind
(iv) almost 5.5-6% ofthe village population suffer
from osteoarthritis.
(v) Further, the COPCOPD Bhigwan modelforthe
studyofthe epidemiologyofRA in aprospective
manner, presentedbyDr Chopra initially to the
working group on RA and later to the
participants ofthe meeting, was adoptedby the
WHO BJD, in place ofthe proposed modelfor
future applicatiOn.
The Bhigwan COPCORD is also carrying out the
immunogenetic studies of the rural patients and
community in collaboration with Prof. Alan Silman &
colleagues at the University of Manchester, UK. The
Bhigwan COPCORD will also identify risk factors in
causation of MSD, and design and evaluate control
strategies.
Dr. N. Khaltaev, Co-ordinator, Non-Communicable
Diseases, WHO, and Secretary to the WHO-BJD
meeting, had earlier visited village Bhigwan to evaluate
the COPCORD project, and further endorsed a WHO
sponsorship to publish and distribute basic health
education material in the village.
Prof Sunderam, presented his statistics on spinal
disorders basedon hospitalexperience in Madras, with
specialreference to spinal injuries andtuberculosis. He
further described the problems of collecting hard core
epidemiological data in the Indian scenario.
Dr. Mittal expressed his concern on the lack ofdata
on osteoporosis in developing countries, and further
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state, though the lackoftechnologydid not allow precise
diagnosis, the disease was rampant and often in
association with vitamin D deficiency The lalter was
acceptedby the participants.
Prof. D. Mohan, an engineer from liT, New Delhi,
and incharge of a WHO collaborating center on
transportation injuries and prevention, cited his socio-
economic cultural data from village surveys carried out
in North India, and further highlighted the aetiologyand
prevention of limb trauma. Besides RTA, he also
emphasizedthe needto curb agriculture-relatedtrauma
in the developing countries.
At present, India does not have a national
programme of any kind concerning RMSDI
rheumatic diseases.
The WHO-BJD future strategy
The key goal is summed up in its slogan "keep people
moving". Based on the proceedings and conclusions of
the recently conducted scientific expert group meeting
in Geneva, and available world wide statistics, the WHO
BJD hopes to accomplish the following goals in the
current decade :-
(I) raise awarenessofthe growing burden ofRMSD
in society:
This will be done through translation of the
epidemiological global burden of RMSD into
financial costs. This will be further
communicated to the national decision makers
in different countries, who will then devise
methods and means to reduce the RMSD burden
to society by shifting indirect to direct health
care costs.
(2) promote prevention of RMSD and empower
patients through education campaigns:
The BJD national action networks (NAN), in
close laison with the national Govt health
authorities and agencies, and the International
WHO-BJD Steering Group, will design public
awareness and education campaigns. Patients
must be empowered to participate in their own
health care.
(3) advance research in prevention diagnosis and
treatment of RMSD, including rheumatic
disorders.
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It is expected to tripple the existing research
funding during the decade
(4) improve diagnosis and treatment of R.MSD.
The specific goal would be to influence the
medical schools and colleges to impart a better
and practical training program, ofat least 6 months, to
the undergraduates.The diagnostic and treatment skills
of the GP need to be improved. Similar proposals
will be made for other medical groups engaged in care
ofRMSD.
Finally, it is hoped that at the end ofthe current decade
there will be 25% reduction in expected increase injoint
destruction by arthritis, osteoporotic fractures, severly
injured people, and indirect health. cost for spinal
disorders.
To begin with, the WHO BJD Steering
Group expects at least ·100 countries to be
actively participating in achieving somc of
the above mentioned objectives of the BJD
decade by 2002.
The BJD national action network (NAN) for India
In close liaison with the International Steering
Committee, a NAN committee for India has
been proposed and accepted. The committee will
consist of Prof. T. K. Shanmugasunderam (Chairman),
Prof. D. Mohan(Co-ordinator), Dr. Arvind Chopra
(Secretary), Dr. A. Mittal, Dr. S. Goyal.
Thecommitteewill initiate dialogue with Government
Health authorities and other concerned national
associations and agencies to promote the activities
of the WHO-BJD in India. It will co-opt experts
from related medical disciplines from different parts of
India.
The initial attempt will be to create a national data
base on some of tbe RMSD, and encourage data
collection through well organised epidemiologically
driven multicentric studies.
In all earnest and at the earliest, the Indian NAN
committee will try to obtain an official endorsement of
the WHO BJD project by the Government ofIndia.
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